Joseph Bratica
Comptroller/Controller/Auditor chez SAREPTA THERAPEUTICS, INC.
Profil
Joseph Bratica est vice-président et contrôleur de gestion chez Sarepta Therapeutics, Inc. Il a précédemment occupé le poste de directeur de la comptabilité chez Creative Biomolecules, Inc. et celui de vice-président des finances et contrôleur chez ARIAD Pharmaceuticals, Inc. Il est titulaire d'un diplôme de premier cycle de l'université de Suffolk.
Postes actifs de Joseph Bratica
| Sociétés | Poste | Début |
|---|---|---|
| SAREPTA THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01/03/2017 |
Anciens postes connus de Joseph Bratica
| Sociétés | Poste | Fin |
|---|---|---|
| ARIAD PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01/01/2016 |
Creative Biomolecules, Inc.
 Creative Biomolecules, Inc. BiotechnologyHealth Technology Creative Biomolecules, Inc. develops products for human tissue regeneration and organs based on morphogenic proteins. The company was founded by Roberto Crea, Fred Bernard Craves and Charles Cohen and is headquartered in Hopkinton, MA. | Comptroller/Controller/Auditor | 01/01/1994 |
Formation de Joseph Bratica
| Suffolk University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SAREPTA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Creative Biomolecules, Inc.
Creative Biomolecules, Inc. BiotechnologyHealth Technology Creative Biomolecules, Inc. develops products for human tissue regeneration and organs based on morphogenic proteins. The company was founded by Roberto Crea, Fred Bernard Craves and Charles Cohen and is headquartered in Hopkinton, MA. | Health Technology |
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |
